Rajesh Kumar Thaper
23Patents
6h-index
42Co-inventors
65Inventor score
Filing activity: Mar 13, 1997 → Dec 31, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6528660B1 | Process for the production of amorphous atorvastatin calcium | Human Necessities | 21 | Expired |
| US5763646A | Process for manufacturing simvastatin from lovastatin or mevinolinic acid | Chemistry; Metallurgy | 21 | Expired |
| US5917058A | Process of lactonization in the preparation of statins | Chemistry; Metallurgy | 15 | Expired |
| US8278461B2 | Stable amorphous form of carvedilol dihydrogen phosphate with stabilizer | Human Necessities | 9 | Active |
| US5939564A | Process of lactonization in the preparation of statins | Chemistry; Metallurgy | 9 | Expired |
| US5763653A | Key intermediates in the manufacture of simvastatin | Chemistry; Metallurgy | 9 | Expired |
| US9365526B2 | Process for the preparation of dasatinib and its intermediates | Chemistry; Metallurgy | 6 | Active |
| US6541511B1 | Methyl analogs of simvastatin as novel HMG-CoA reductase inhibitors | Chemistry; Metallurgy | 2 | Expired |
| US8124783B2 | Process for producing 1-benzyl-4-[5,6-dimethoxy-1-indanon-2-yl)methyl] piperidine or its salt thereof via novel intermediate | Chemistry; Metallurgy | 2 | Active |
| US7872144B2 | Process for producing biphosphonic acids and forms thereof | Chemistry; Metallurgy | 1 | Active |
| US8440823B2 | Process for the preparation of erlotinib or its pharmaceutically acceptable salts thereof | Chemistry; Metallurgy | 1 | Active |
| US8614329B2 | Polymorphs of sorafenib acid addition salts | Chemistry; Metallurgy | 0 | Active |
| US8716477B2 | Crystalline forms of bosentan salts and processes for their preparation | Chemistry; Metallurgy | 0 | Active |
| US8604208B2 | Polymorphs of sorafenib acid addition salts | Chemistry; Metallurgy | 0 | Active |
| US7795451B2 | Polymorphic forms of fluvastatin sodium and process for preparing the same | Chemistry; Metallurgy | 0 | Active |
| US8044196B2 | Process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine | Chemistry; Metallurgy | 0 | Active |
| US9150542B2 | Process for the preparation of crystalline form I of methanesulfonate salt of dabigatran etexilate | Chemistry; Metallurgy | 0 | Active |
| US8552197B2 | Sorafenib ethylsulfonate salt, process for preparation and use | Human Necessities | 0 | Active |
| US8853411B2 | Process for the preparation of dexlansoprazole | Chemistry; Metallurgy | 0 | Active |
| US9085556B2 | Salts of dexlansoprazole and their preparation | Chemistry; Metallurgy | 0 | Active |
| US8609854B2 | Process for the preparation of sorafenib tosylate | Chemistry; Metallurgy | 0 | Active |
| US7678927B2 | Process for lactonization in the preparation of statins | Chemistry; Metallurgy | 0 | Expired |
| US8618305B2 | Sorafenib dimethyl sulphoxide solvate | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.